Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

became the first CRISPR therapy approved by the US Food and Drug Administration (FDA) in December 2023. With AWS on board, ...

Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and animals. To better monitor the emergence and spread of resistance, ...

6 CRISPR’s capacity to cut and modify genes ... particularly in settings with limited laboratory resources. 9 An expert in the design and development of bioanalytical materials, sensors, and ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases.

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

With AWS on board, ElevateBio says that it can design high-level CRISPR proteins with improved therapeutic potential both for partners and internal pipeline development. The company’s technology ...